Literature DB >> 3599207

Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma model.

J L Mohler, A W Partin, D S Coffey.   

Abstract

Many grading systems for prostatic carcinoma exist; however, none allows pathologists to accurately predict the prognosis of individual patients. Examination of dead fixed histological sections of malignancies may not be the best way to predict the biological behavior of living dynamic tumors. We have developed a grading system that reproducibly characterized the motility of living cancer cells. In the Dunning R3327 rat prostatic adenocarcinoma model, three sublines of high metastatic potential (greater than 90%) were distinguished from four sublines of low metastatic potential (less than 10%). Individual cells from these sublines were correctly identified as high or low metastatic in 96% of cases by grading membrane ruffling, pseudopodal extension, and vectoral translation.

Entities:  

Mesh:

Year:  1987        PMID: 3599207     DOI: 10.1016/s0022-5347(17)43037-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Molecular mechanisms of cell motility.

Authors:  E A Turley
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

Review 2.  Cellular motility and prostatic carcinoma metastases.

Authors:  J L Mohler
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

3.  Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model.

Authors:  J L Mohler; W E Bakewell; Y Sharief; W B Coleman; C H Chay; S M Silvers; G J Smith
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

Review 4.  Chemotaxis of metastatic tumor cells: clues to mechanisms from the Dictyostelium paradigm.

Authors:  J Condeelis; J Jones; J E Segall
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

5.  Biometric assessment of prostate cancer's metastatic potential.

Authors:  C R Cooper; N Emmett; S Harris-Hooker; R Patterson; D B Cooke
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.